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Abstract
Background: “Use it or lose it” is a well known saying which is applicable to boys with Duchenne Muscular
Dystrophy (DMD). Besides the direct effects of the muscular dystrophy, the increasing effort to perform activities,
the fear of falling and the use of personal aids indirectly impair leg and arm functions as a result of disuse. Physical
training could oppose this secondary physical deterioration. The No Use is Disuse (NUD) study is the first study in
human subjects with DMD that will examine whether a low-intensity physical training is beneficial in terms of
preservation of muscle endurance and functional abilities. The study consists of two training intervention studies:
study 1 “Dynamic leg and arm training for ambulant and recently wheelchair-dependent boys with DMD and,
study 2 “Functional training with arm support for boys with DMD who have been confined to a wheelchair for
several years”. This paper describes the hypotheses and methods of the NUD study.
Methods: Study 1 is an explorative randomized controlled trial with multiple baseline measurements. Thirty boys
with a DNA-established diagnosis of DMD will be included. The intervention consists of a six-months physical
training during which boys train their legs and arms with active and/or assisted cycling training equipment. The
primary study outcomes are muscle endurance and functional abilities, assessed with a Six-Minute Bicycle Test and
the Motor Function Measure. Study 2 has a within-group repeated measurements design and will include ten boys
with DMD who have already been confined to a wheelchair for several years. The six-months physical training
program consists of 1) a computer-assisted training and 2) a functional training with an arm support. The primary
study outcome is functional abilities of the upper extremity, assessed with the Action Research Arm Test.
Discussion: The NUD study will fill part of the gap in the current knowledge about the possible effects of training
in boys with DMD and will increase insight into what type of exercise should be recommended to boys with
DMD. The study will finish at the end of 2010 and results are expected in 2011.
Trial registration: The Netherlands National Trial Register1631
Background
Duchenne Muscular Dystrophy (DMD) is an inherited X
chromosome-linked recessive myopathy which affects
approximately 1/4200 live-born boys[1]. DMD is charac-
terized by a total, or near-total (<3%), absence of the
cell membrane protein dystrophin. The absence of dys-
trophin results in a steady degradation of muscle fibers
that causes progressive loss of muscle strength and
functional abilities[2,3]. Boys with DMD are usually con-
fined to a wheelchair at the age of ten years[4] and have
a median life expectancy of thirty years with spinal sur-
gery and assisted ventilation[5]. Although ongoing stu-
dies show promising therapies that target disease cause,
there is still no curative (pharmaco)therapy available
and, thus, treatment remains symptomatic. An impor-
tant aim in the management of boys with DMD is to
preserve functional abilities for as long as possible[6].
Delaying the loss of functional abilities is relevant for all
activities in daily life and may optimize independence in
boys with DMD.
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any medium, provided the original work is properly cited.The loss of functional abilities is primarily the result
of a progressive decrease in muscle strength and muscle
endurance during the course of the disease[4,7]However,
increasingly limited physical and social possibilities gra-
dually cause a secondary reduction of physical activity.
Indeed, the increasing amount of energy a certain activ-
ity costs, the increasing frequency of falling (with the
need for help to stand up), and the developing fear of
falling further reduce leg and arm activities, resulting in
disuse of the musculoskeletal and cardiorespiratory sys-
tems[8]. The use of an electrical wheelchair limits arm
functions (like reaching and lifting) even more, since a
top blade and a central operating joy stick force boys to
function within the confines of the wheelchair. As the
increased sedentary lifestyle results in progressive disuse,
secondary physical deterioration will occur in all boys
with DMD. Disuse in DMD thus can be defined as the
discrepancy between a boy’s potential capacity and his
actual performance. To underscore the importance of
disuse, previous studies have shown that the presence of
hip, knee and elbow flexion contractures is strongly
related to the onset of wheelchair dependence[4].
Another example is that boys with DMD have a higher
risk of bone fractures due to osteoporosis caused by
unloading[9]. Fractures as a result of falling are followed
by a loss of ambulation in 20-40 percent of the cases
[10,11]. In these aspects, the well-known saying “use it
or lose it” is certainly applicable to boys with DMD.
Physical training could oppose the secondary deteriora-
tion of muscle tissue and the loss of functional abilities as
a result of disuse. However, the number of studies that
examined the effects of training in DMD is limited, and
only a few training studies are reported in human
subjects with DMD. These studies focused on resisted
exercises in ambulatory boys and concluded that sub-
maximal resistance exercises had only limited positive
effects on muscle strength and timed functional tests
(such as the time it takes to walk 23 feet) but, impor-
tantly, they did not cause physical deterioration[12-14].
Recent studies in mdx mice (an animal model for DMD)
concluded that voluntary wheel running (dynamic train-
ing) had positive effects on muscle strength[15] and fati-
gue resistance[15-17]. In addition, non-weight bearing
low-intensity exercises (like swimming) had no detrimen-
tal effects in mdx mice[18]. However, extrapolating data
from animal studies to humans should only be done with
great caution because of differences in phenotypic
expression and biomechanical differences between
humans subjects and animal models with muscular dys-
trophy[19]. Based on the currently available evidence,
and clinical experience, international guidelines recom-
mend ambulatory boys to perform voluntary (eventually
mechanically-assisted) active exercises (such as swim-
ming) and to avoid eccentric exercises. Non-ambulant
boys are advised to perform mobilizing passive or
actively-assisted mobilizing exercises to maintain postural
symmetry and sitting comfort[20].
The mechanisms by which training may oppose the
deterioration of muscle tissue is unclear. Muscle fibres
in DMD are abnormally vulnerable to contraction-
induced injury due to the absence of mechanical reinfor-
cement of the sarcolemmal membrane[21]. Therefore,
eccentric exercises should be avoided[22]. On the other
hand, work-induced damage can enhance muscle regen-
eration and repair[23], and low-stress exercise may pro-
duce beneficial effects on myofiber contractility and
energetic efficiency[21]. For example, low-intensity
training decreased oxidative stress markers[24] and
caused a shift from fast-twitch muscle fiber type 2 to
slow-twitch muscle fiber type 1 in mdx mice[16]. Slow-
twitch muscle fibers are more resistant to muscle fiber
degeneration[16,25]. In addition, corticosteroids could
support the beneficial effect of training in DMD, since
steroids may prevent post-exercise deterioration of ske-
letal muscle[22].
The currently recommended voluntary exercises to
maintain comfort and symmetry[6] are widely used in
daily practice and assume that low-intensity training is
beneficial and not harmful for boys with DMD. How-
ever, these recommendations are mainly based on the-
ory and there is a need for more research to justify
these recommendations and to define the optimal exer-
cise programmes[26]. As we expect that a low-intensity
training may slow-down the secondary decline of muscle
endurance and functional abilities (figure 1), we devel-
oped the No Use is Disuse (NUD) study protocol to
answer the clinically relevant questions whether low-
intensity physical training in boys with DMD is benefi-
cial and does not cause further harm. The NUD study is
the first to examine the effects of low-intensity physical
training in human subject with DMD and will fill part
of the gap in current knowledge about the possible
effects of training in boys with DMD. The study consists
of two training intervention studies: study 1 “Dynamic
leg and arm training for ambulant and recently wheel-
chair-dependent boys with DMD and, study 2 “Func-
tional training with arm support for boys with DMD
who have been confined to a wheelchair already for sev-
eral years”. This paper describes the hypothesis and
methods of the NUD study.
Methods
Study 1 Dynamic leg and arm training
Design
Study 1 is an explorative randomized controlled trial
with multiple baseline measurements. Randomization is
stratified according to the ambulatory status (ambulant/
non-ambulant) of the boys and the boys are allocated to
Jansen et al. BMC Pediatrics 2010, 10:55
http://www.biomedcentral.com/1471-2431/10/55
Page 2 of 15the intervention group or the control group in a 2:1
ratio. The intervention group receives dynamic exercise
treatment, whereas the control group receives usual care
(no specific intervention) during 24 weeks. After this
period, the control group will also receive the physical
training. Randomization is performed by an independent
statistician. Despite randomization, differences in base-
line characteristics between the intervention group and
the control group may still be present due to the rela-
tively small number of participants. For this reason,
multiple baseline measurements are performed that will
allow us to do within-subject analyses as well. Assess-
ments are not blinded, because it was considered vir-
tually impossible to prevent the boys from revealing
their group allocation to the assessor.
Participants
Thirty ambulatory or recently wheelchair-dependent
boys with a DNA-established diagnosis of DMD will be
included (figure 2). There are an estimated four hundred
boys with DMD in the Netherlands. Inclusion and
Figure 1 Hypotheses
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will be recruited from the Dutch Duchenne Parent Pro-
ject (DPP) database. Members of the DPP will receive
written information and a registration form. Addition-
ally, we will place an advertisement on the website of
the Vereniging Spierziekten Nederland (VSN), and reha-
bilitation physicians affiliated with the VSN will be
asked to make potential participants aware of the NUD
study. After registration, interested potential participants
are visited by the primary investigator (MJ) at home for
providing further information. Parents, and participants
who are over 12 years of age, need to give written
informed consent. The study protocol was approved by
the Medical Ethics Committee Arnhem-Nijmegen, the
Netherlands.
Intervention: dynamic leg and arm training
Boys train their legs and arms with bicycle training
equipment (KPT Cycla, Kinetic, France). As this type of
training equipment can be used actively or with electri-
cal motor support, it allows a combination of active and
passive bicycle training. Physical training is additional to
any regular therapy or daily physical activity that boys
already take part in, yet all possible co-interventions are
registered.
Figure 2 Progress study 1 Dynamic leg and arm training. This flowchart is a preliminary version. Final numbers may change depending on
eligibility as recruitment is not yet complete.
Table 1 Inclusion and exclusion criteria study 1
Inclusion criteria Exclusion criteria
A DNA-established diagnosis of DMD Other disabling diseases influencing mobility
Boys who are at the end of their ambulation phase, and:
-need ≥5 sec. to get up from the floor or
-are not able to get up from the floor or
-are not able to bicycle without assistance
-are dependent on a wheelchair to move over a long distance (>500 m)
Boys with a clinical symptomatic
cardiomyopathy
Boys <6 years old
Boys who recently became wheelchair-dependent (approximately 1-2 years after they stopped
walking), and:
-are able to touch the top of their head with both hands without assistance or
-are not able to bicycle without assistance
-are able to use a hand-operated wheelchair
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preferences) during 30-min sessions (15 min leg and 15
min arm training), five days per week during 24 weeks.
They are instructed to cycle with a continuous speed
and stimulated to reach 700-1000 revolutions with both
their legs and arms during each training session without
getting too tired. Cycling characteristics are standardized
(figure 3) and crank-arm length is adjusted to the child’s
height (e.g. a short crank-arm length for small legs and
a r m s ) .B o y sa r ef r e et oc h o o s ew h e nt h e yw o u l dl i k et o
train, their training sequence (first arms or legs) and
whether they want a break between the two 15 min
training sessions or not. However, these training agree-
ments are decided beforehand and registered in a train-
ing contract to which they should adhere. Additionally,
the boys are recommended to train while watching tele-
vision to make the training more pleasurable.
Based on general training principles and based on the
results from previous training studies in boys with DMD
and in animal models of DMD, the training intensity is
low to moderate. Intensity is determined by an adjusted
and modified Six-Minute Bicycle ergometer Test (see
study outcomes). Boys are encouraged to reach as many
revolutions as possible during this sub-maximal test. The
number of revolutions is an indication for training inten-
sity (level of electrical assistance). After six minutes of
rest, boys cycle for three more minutes at the indicated
training intensity. During this period, they should be able
to cycle with a continuous speed of 60 revolutions per
minute (RPM) with a perceived level of exertion ranging
from ‘a little tired’ to ‘getting more tired’, as assessed
with the OMNI Scale of perceived exertion[27]. The pri-
mary investigator will check the training intensity once
again during a 15 min training session within two weeks
after the start of the intervention period. This control is
carried out in a home setting, so that training posture
can be checked as well. When boys are not able to bicycle
at a continuous speed of approximately 60 RPM without
having pain or maintaining the level of ‘getting more
tired’, the training intensity will be lowered.
As described above, training intensity is based on the
ability to bicycle at a continuous speed and perceived
exertion. Intensity is, thus, not based on peak heart rate,
which is common in the literature on physical exercise
training. The reason for this is twofold. Firstly, boys
with DMD have a higher resting heart rate (110 ± 12
beats/min) compared to healthy controls (94 ± 7 beats/
min )[28]. Additionally, boys with DMD are often forced
to terminate a bicycle ergometry test while their peak
h e a r tr a t ei so n l y1 2 0 - 1 3 0b e a t s / m i n ,s i n c et h em a i n
limiting factor during ergometry seems to be not their
oxygen transport but their ‘peripheral’ capacity (muscle
endurance, anaerobic power and muscle strength)[7].
Boys are instructed to send their daily number of
revolutions and their perceived levels of exertion to the
p r i m a r yi n v e s t i g a t o rb yap o s t a lq u e s t i o n n a i r eo n c e
every two weeks, together with an overstrain question-
naire. Parents and their boys are informed by telephone
when compliance is inadequate or when other problems
(such as signs off overstrain: see adverse events) are
identified and children are encouraged to resume the
training or to adjust the training intensity.
Study outcomes
Study outcomes include measurements at the levels of
body functions and structures, activities and participa-
tion as defined by the International Classification of
Functioning, Disability and Health (ICF) [29]. Environ-
mental characteristics (school type and home status) are
assessed at baseline. Demographic variables (age, weight
and arm span), the use of medication (such as
Figure 3 Posture during dynamic leg and arm training
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of physical activity are registered during each session.
The assessments of boys in the intervention group are
conducted during the baseline period (T0: at baseline;
T1: after 4 weeks; T2: after 8 weeks), the training period
(T3: after 12 weeks; T4: after 24 weeks) and the follow-
up (T5: 4 weeks after the end of the training; T6: 24
weeks after the end of the training). The assessments of
boys in the control group are conducted during the
baseline period (T0: at baseline; T1: after 4 weeks; T2:
after 8 weeks), the control period (T3: after 12 weeks;
T4: after 24 weeks), the subsequent training period (T5:
after 12 weeks of training; T6: after 24 weeks of train-
ing) and during the follow-up (T7: 4 weeks after the end
of the training). Assessments take place at the depart-
ment of Rehabilitation of the Radboud University Nij-
megen Medical Centre (T0, T2, T4, T6), but also at
home (intervention group: T1, T3, T5; control group:
T1, T3, T5, T7) to reduce the practical burden on the
participants. All data are collected by the (trained) pri-
mary investigator (MJ). (figure 4)
Primary outcomes
Bicycle ergometry: Six-Minute Bicycle Test
Muscle endurance, in this study defined as ‘the ability
to sustain a power without the occurrence of peripheral
fatigue’, is assessed with an adjusted and modified
bicycle ergometer test for both the lower and upper
extremities. Bicycle ergometry has been used in many
studies to examine the (an)aerobic performance in
healthy children and children with disabilities, and sev-
eral exercise protocols are available. However, these pro-
tocols are not feasible for boys with DMD, since large
muscle groups are affected in DMD and initial load and
subsequent increments of load are often too hard to
sustain for these patients[7,30]. Muscle endurance is,
therefore, examined with a recently developed motor-
assisted (passive mode 1, no-load speed 7 RPM) Six-
Minute Bicycle Test by which boys are instructed to
cycle as fast as possible i.e. to make as many cycling
r e v o l u t i o n sa sp o s s i b l e .B o ys start with a test for their
legs and, thereafter, perform the same (arm cranking)
test with their arms.
The occurrence of muscle fatigue during bicycle ergo-
metry is assessed objectively with bipolar surface elec-
tromyography (sEMG), since peripheral fatigue is
reflected as an increase in the amplitude and a decrease
in the median frequency of the sEMG signal[31,32].
These parameters were found to be responsive to
changes in muscle endurance during an exercise pro-
gram[33,34]. Electrodes are placed unilaterally (right leg,
right arm) on the m. rectus femoris, m. vastus medialis,
m. biceps femoris, m. tibialis anterior, m. biceps brachii,
m. triceps brachii and m. deltoideus. Electrode place-
ment procedures will follow the recommendations for
Sensor and Sensor Placement Procedures for surface
electromyography[35]. Data will be registered with an
EFA system (Twente Medical Systems International).
The occurrence of muscle fatigue is also assessed sub-
jectively with the OMNI Scale for perceived exertion
[27]. The OMNI Scale is reliable and valid over a wide
range of dynamic exercise intensities in children[27,36].
Motor Function Measure
The MFM is a recently developed instrument to assess
motor function in ambulant and non-ambulant patients
with neuromuscular diseases (NMD) aged 6-62 years
[37]. The MFM has shown excellent internal consistency
and good to excellent intra- and interrater reliability in
French neuromuscular patients[37]. Vuillerot et al.[38]
showed that the MFM is able to measure changes in
m o t o rf u n c t i o no v e rt i m ei nb o y sw i t hD M D .A n
ongoing study examines validity and applicability of the
MFM in rehabilitation institutes in the Netherlands.
Secondary outcomes Table 2 shows an overview of the
secondary study outcomes and their psychometric
properties.
Adverse events
All adverse events will be recorded. The study will be
terminated prematurely for an individual participant
when training is excessive and remains excessive after a
reduction of the training intensity. Signs for overstrain
Figure 4 Measurements study 1. BP (Baseline period), IP (Intervention period), FU (Follow-up), CP (Control period)
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Level Study outcome Measurement tool Psychometric properties Assessment
Body
structures
and functions
Muscle endurance Six-Minute Bicycle Test* Feasible for ambulant and non-ambulant boys
with DMD (pilot study, unpublished data)
T0, T2, T5
Joint mobility
(PROM)
Goniometry[55] (knee ext*, ankle dfl*,
shoulder abd*▪, elbow ext*▪, wrist ext▪, wrist
radial and ulnar dev▪)
Standardized methods are feasible[56] and
have good intra- and inter-rater reliability in
DMD[57]
Passive wrist radial deviation is correlated with
functional hand activities[58] and lower
extremity contractures are related to onset of
wheelchair reliance in DMD[4]
All
Muscle strength Modified MRC[59] (hip ext*, knee ext* ankle
dfl*, shoulder abd*▪, elbow ext*▪, wrist ext▪)
Moderate to good intra-rater reliability[59] and
acceptable inter-rater reliability in DMD after a
training session[60]
Muscles with MRC grade 4 or 5 are difficult to
measure with MMT, but muscles with MRC
grade ≤3 are more difficult to measure with
HHD[4]
All
Muscle atrophy,
intra-muscular
fibrosis and fatty
infiltration
Quantitative skeletal muscle ultrasonography
(muscle thickness and echo intensity) [61]: RF,
TA, BB, FF*▪
Good inter-rater agreement in children[62]
High predictive values to discriminate
between children with and without a NMD
[63]
T2, T5, T6/T7*
Bone density Dexascan (femur and lumbar spine)* Changes in bone mineral density can be
detected with confidence in healthy boys ≥10
years after 6 months and in younger boys
after 12 months[64], but a change in body
shape may influence scan results[65]
Conventional
protocol for
each boy
Incidence of
fractures
Semi-structured interview* All
Activities Functional abilities Motor Function Measure[37] (D1*, D2*, D3*▪) Excellent internal consistency for the global
scale and the subscales in NMD[37]
Excellent to moderate intra- and inter-rater
reliability in NMD[37]
Good face validity, convergent validity and
discriminant validity in NMD[37]
Sufficiently sensitive to detect changes in the
total score in DMD[66]
Total score predicts loss of ambulation in
DMD[67]
All
Upper limb
function
Action Research Arm Test[40,41] ▪ Excellent intra-rater, inter-rater and test-retest
reliability in stroke patients[40,41]
Highly correlated with the Fugl-Meyer score
47
and Functional Independence Measure
48 in
stroke patients
Suitable to detect changes over time in stroke
patients[42]
All
Functional abilities
(grading)
Vignos* and Brooke Scale*▪ [56] Good inter-rater and intra-rater reliability[57,57]
and correlated with timed tests[46,68,69] in
DMD
All
Functional
mobility
Functional Mobility Scale[70] * A clinically feasible, valid and reliable tool in
CP[70,71]
All
Functional abilities
(timed tests)
Timed and graded functional tests (and total
GSGC score) [72]: walk 10 meters, climb 3
stairs, rise from the floor and rise from a
chair*
Good to excellent intra- and inter-rater
reliability in DMD[57,73]
Sensitive to change in DMD: a small reduction
in muscle force was accompanied by a large
increase in time it takes to complete
functional tests[74]
All (gait, stairs
and chair only
in the
hospital)
Finger dexterity Nine-hole Peg Test[75] *▪ Moderately high test-retest reliability, high
inter-rater agreement and adequate
concurrent validity in school-age children[76]
All
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longed post-exercise muscle pain, a severely uncomfor-
table feeling during or after the training and extreme
(muscle) fatigue (OMNI scale > 6).
Sample size
The average rate of decline (mean and standard
deviation (SD)) of muscle endurance and functional
abilities in boys with DMD, as assessed with bicycle
ergometry and the Motor Function Measure (MFM),
is unknown. Therefore, no sample size can be calcu-
lated for these primary outcomes. However, it is
anticipated that multiple baseline measurements will
increase the chance of finding statistically significant
changes in the selected outcome measures. For rea-
sons of convenience, and because this RCT should be
regarded as a first explorative study, we decided to
include 20 boys in the intervention group and 10
boys in the control group.
Analysis
A two-way analysis of variance (ANOVA) will be used
to examine the effects of dynamic leg and arm training
on the primary outcomes. Secondary outcomes will be
treated similarly or by non-parametric analyses depen-
dent on the type of outcome (interval or ordinal). Data
will be analyzed with SPSS version 16.0 and an alpha
level of 0.05 will be used to decide on statistical
significance.
Study 2 Functional training with arm support
Design
Study 2 has an observational one-group design using
repeated measurements, because we anticipate that it
Table 2 Outcome measures and psychometric properties (Continued)
Hand function Jebsen-Taylor Hand Function Test[77] ▪ Good test-retest reliability in DMD[58]
Strongly correlated with muscle strength of
the wrist extensors[58], radial deviation range
of motion[58] and the Brooke scale[46] in
DMD
T2, T4, T5
Functional status PEDI[78,79] (selfcare*▪ and mobility*) Good inter-rater and test-retest reliability[80],
content validity[79] and discriminative validity
[81] in children with various diagnosis
Feasible for evaluative purposes in CP[81,82]
T0, T2, T4, T6/
T7*
Perceived manual
abilities
Abilhand[83] ▪ Abilhand-kids[84] * The Rasch-derived Abilhand is moderately
related to grip and key pinch strength, has
good test-retest reliability and may be
sensitive to change in stroke patients[85]
The Abilhand-kids has good test-retest
reliability and a higher independence in gross
motor function is associated with a higher
manual ability in CP[84]
T0, T2, T4, T6/
T7*
Quality of upper-
limb motor
function
Melbourne Assessment of Unilateral Upper
Limb Function[86] (item 1,2,3,10,11 and16)
extended with an upper limb motion analysis
(Vicon Motion Systems) with 8 cameras▪
The Melbourne Assessment has moderate to
high intra- and inter-rater reliability[87] and
excellent construct validity in CP[88]
A motion capture analysis system can measure
task performance with an upper-limb orthosis
[45], but soft tissue artefacts may negatively
influence accuracy[49]
T2, T4
Incidence and fear
of falls
Semi-structured interview* All
Participation HRQoL KIDSCREEN-52[89](child- and parental
questionnaire)*▪
Acceptable levels of reliability and validity in
children and adolescents[90]
Children’s most important in their lives
generally map well to the items in KIDSCREEN
[91]
T0, T2, T4, T6/
T7*
Demographic
variables
Weight and height Body weight (kg)*▪, standing height* (cm)
and arm-span*▪ (cm)
T0*, T2, T4,
Y6/T7*
Co-factors Co-interventions Semi-structured interview*▪ All
Physical activity Semi-structured interview (according to the
PAQ-C[92] and the 60-min MVPA measure
[93])*▪
All
Symbols:* = study 1 ‘Dynamic leg and arm training’, ▪ = study 2 ‘Functional training with arm support’
Abbreviations: DMD: Duchenne Muscular Dystrophy; PROM: Passive Range of Motion; ext: extension; dfl: dorsal flexion; abd: abduction; dev: deviation; MRC:
Medical Research Council Scale; RF: m. Rectus Femoris; TA: m. Tibialis Anterior; BB: m. Biceps Brachii; FF: forearm flexors; NMD: Neuromuscular Disease; GSGC:
Gait, Stairs, Gowers, Chair; PEDI: Pediatric Evaluation of Disability Inventory; CP: cerebral palsy; HRQoL: Health-Related Quality of Life; PAQ-C Physical Activity
Questionnaire for older children; MVPA: Moderate-to-Vigorous Physical Activity
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boys for an RCT in the Netherlands. This problem is
related to the fact that boys with DMD who have been
confined to a wheelchair already for several years often
experience many barriers, such as a lack of time due
to therapy obligations and homework. It is also vir-
tually impossible for them to do without their electric
wheelchair for a couple of days to build up the
required arm support for this study. In addition, the
number of boys at this stage in the course of DMD is
low (i.e. an estimated 120 boys in the Netherlands)
and, it is expected that some of these boys already use
an arm support, which is an exclusion criteria for
participation.
Participants
Ten wheelchair-dependent boys with a DNA-established
diagnosis of DMD will be recruited in the same way as
the participants of study 1 (figure 5). Inclusion and
exclusion criteria are described in table 3. Participants
will receive written information and will be visited by
the primary investigator at home for providing further
information. Both parents and participants will need to
give written informed consent. The study protocol was
approved by the Medical Ethics Committee Arnhem-
Nijmegen, the Netherlands.
Intervention
The six-months physical training consists of 1) a com-
puter-assisted training and 2) a functional training of
the non-dominant arm and hand (i.e. the hand one does
not use for writing) with a mechanical or an electrical
arm support (Dynamic Arm Support Top/Help, Focal,
Tilburg, the Netherlands) (figure 6). Boys who are
unable to touch their nose with a mechanical arm sup-
port (due to insufficient muscle strength) will receive an
electrical arm support. The arm support transposes
shoulder movements into movements of the forearm
and hand, which increases functional abilities and joint
range of motion in boys with DMD. During the first
baseline measurement (T0), boys will try to fit the arm
support under supervision of an experienced representa-
tive of Focal (the manufacturer of the TOP arm
support) and the primary investigator. Training of the
non-dominant arm is additional to any regular therapy.
All co-interventions will be registered.
Computer-assisted training Boys play “Furballhunt”
(developed by Roessingh Research and Development B.
V. (M.A. Jannink), Enschede, the Netherlands) to prac-
tice targeted forward and sideward reaching movements
(ipsi- and contra-lateral) as well as lifting movements
during five days per week. Furballhunt is a computer
Figure 5 Progress study 2 Functional training with arm support. This flowchart is a preliminary version. Final numbers may change
depending on eligibility as recruitment is not yet complete.
Jansen et al. BMC Pediatrics 2010, 10:55
http://www.biomedcentral.com/1471-2431/10/55
Page 9 of 15game that was originally developed to improve arm
function in children with cerebral palsy using a virtual
reality environment. Furballhunt is based on motion
capture technology and uses a webcam (in this study:
Logitech QuickCam E3500) to detect gross shoulder and
elbow movements. Birds ("Furballs”) fly from their bird-
house to a tree branch while the boy holds his hand in
front of his navel. Boys have to touch the Furball when
i ts i t sd o w no nat r e eb r a n c h .T h ef a s t e rb o y sc h a s e
away Furballs, the higher their score. A virtual reality
computer game is considered to be a motivational tool
for training in children[39].
Boys play five games of Furballhunt (30 Furballs per
game, 30 sec of rest between games) per day at home.
T h en u m b e ro ft r e eb r a n c h e s( 3 ) ,g a m es p e e d( 5 / 1 0 ) ,
the number of Furballs (30) and the sequence of games
are standardized. Training intensity is low to moderate,
which means that boys are allowed to perceive their
exertion as ‘getting a little tired’ or ‘getting more tired’
as assessed with the OMNI Scale[27]. Intensity is
adjusted to the physical abilities of the boy by varying
the position of the tree branches, which represent the
targets to move to. Boys are instructed to move their
arm over the full range of motion, which may cause a
feeling of stretch but not pain.
Boys report their training frequency in a diary and
complete an overstrain questionnaire once every two
weeks. Parents and their boys are informed by tele-
phone when compliance is inadequate or when other
problems (such as signs of overstrain: see adverse
events) are identified. Boys are encouraged to resume
the training and to adjust the training intensity, when
appropriate. The date, training time and reaction times
are saved on the computer, so that compliance and
performance can be checked afterwards by the primary
investigator.
Functional training Boys should eat at least one meal
with the arm support twice every week. In addition,
they are instructed “to use the arm support as much as
possible every day”. Boys keep a written record of all
activities they perform with the arm support in a three-
day diary once every two weeks (two weekdays, one
weekend day).
Study outcomes
Study outcomes include measurements at the levels of
body functions and structures, activities and participa-
tion of the ICF[29]. Environmental characteristics
(school type and home status) are assessed at baseline.
Demographic variables (age, weight, arm span), the use
of medication (such as corticosteroids) and any co-
interventions are registered during each session.
After a two-month period for baseline measurements
(T0: at baseline; T1: after 4 weeks; T2: after eight weeks)
to obtain information about the stability of the course of
DMD, training with the arm support takes place for six
months. Assessments take place after 12 weeks (T3) and
24 weeks (T4) training. Finally, one extra measurement
will be done after 12 more weeks (T5) to evaluate to
what extent the possible effects of training have lasted.
Data is collected by the primary investigator (MJ) at the
Figure 6 Dynamic arm support Top/Help.F o c a lM e d i t e c hB V ,
Tilburg, the Netherlands (www.focalmeditech.nl)
Table 3 Inclusion and exclusion criteria study 2
Inclusion criteria Exclusion criteria
A DNA-established diagnosis of DMD Other disabling diseases influencing
mobility
Boys who have been wheelchair-dependent for a few years (approximately 2-5 years after they stopped
walking)
Boys who are able to stand
Boys >20 years old
Boys who have problems with reaching and lifting movements with their arms, and:
-are unable to touch the top of their head (at least with one hand)
-are still able to use their hands for some daily activities
Boys who already use an arm support
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Page 10 of 15department of Rehabilitation of the Radboud University
Nijmegen Medical Centre (T2, T4), but also at home
(T0, T1, T3, T5) to reduce the practical burden on the
participants. (figure 7).
Primary outcome
Action Research Arm Test (ARAT)
As no suitable measure of arm motor function has
been validated for children with NMD, the functional
abilities of the upper extremity (reaching, lifting and
manipulating) are assessed bilaterally with the Action
Research Arm Test (ARAT)[40]. The ARAT is a stan-
dardized tool for the assessment of arm motor function
and capacity (both distally and proximally) and consists
of 19 items in four dimensions: grasp, grip, pinch and
gross movements. The ARAT has shown to be reliable
[40,41], valid[40-42] and suitable to detect changes over
time[42] in stroke patients. The ARAT is performed and
scored following standardized procedures as described
by Yazbatiran[41]. The non-dominant arm is assessed
both with and without arm support.
Secondary outcomes Table 2 shows an overview of the
secondary study outcomes and their psychometric prop-
erties. Both the dominant and non-dominant arms are
assessed. The non-dominant arm is assessed both with
and without arm support.
Adverse events
All adverse events will be recorded. The study will be
terminated prematurely for an individual participant
when training is excessive and remains excessive after a
reduction of the training intensity. Signs for overstrain
are: excessive muscle pain during the training, pro-
longed post-exercise muscle pain, a severely uncomfor-
table feeling during or after the training and extreme
(muscle) fatigue (OMNI scale > 6).
Sample size
This is a first explorative study that will give an indica-
tion of the effect of functional training with arm support
on the functional abilities of the upper extremity in boys
with DMD. In this perspective, no realistic power calcu-
lation can be made. By using a design with multiple
measurements at baseline we anticipate to find statisti-
cally significant effects of the proposed therapeutic
intervention in ten boys with DMD.
Analysis
A one-way analysis of variance (ANOVA) of time will be
used to examine the effects of functional arm training
with arm support on the primary outcome (ARAT). Sec-
ondary outcomes will be treated similarly or by non-
parametric analyses dependent on the type of outcome
(interval or ordinal). Data will be analyzed with SPSS
version 16.0 and an alpha level of 0.05 will be used to
decide on statistical significance.
Discussion
This paper presents the research questions, hypotheses
and methods of the No Use is Disuse (NUD) study in
the Netherlands. The NUD study examines the effects
of low-intensity dynamic physical training in boys at dif-
ferent stages in the course of Duchenne Muscular Dys-
trophy (DMD). It is expected that these dynamic
exercises will be beneficial and will not impose a risk of
muscle or other injury to the boys. This hypothesis is
based on the (limited amount of) evidence that is avail-
able about physical training in children with neuromus-
cular diseases (NMD). In addition, the study was
designed with the extensive input from several experts
in the field of NMD in children (1 pediatric physiothera-
pist, 2 occupational therapists, 1 rehabilitation physician,
1 exercise physiologist, 1 neurologist, 1 clinical neuro-
physiologist and 1 epidemiologist). We will discuss the
most relevant issues and decisions concerning 1) train-
ing (intensity), 2) outcome measures and 3) strategies to
optimize therapy compliance.
Training (intensity)
Boys in both studies are instructed to train five days per
week during 24 weeks. Although this training frequency
is high, it was chosen to elicit as much ‘daily physical
activity’ as possible in every boy. Many boys with DMD,
especially those who are confined to a wheelchair, have
a sedentary lifestyle[28] and do not engage in 60 min of
moderate daily physical activity as recommended by the
WHO for children to reduce their risk of chronic dis-
eases[43]. On the other hand, as boys with DMD already
have a chronic disease, their physical limitations have to
be taken into account to prevent exercise-induced
Figure 7 Measurements study 2. BP (Baseline period), IP (Intervention period), FU (Follow-up)
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Page 11 of 15physical deterioration[44]. Nevertheless, the level of
daily low-intensity physical activity as prescribed in this
study is thought to be safe and effective in reducing dis-
use atrophy and excessive functional loss.
Although training-induced improvements of muscle
functions can normally be expected after six weeks of
physical training[26], we have chosen a training period
of 24 weeks. This relatively long training period is con-
sidered necessary, as the disease progression is relatively
slow, and the expected training effects over time prob-
ably small. We also assume that if boys are able to
adhere to the training regime during these 24 weeks, it
will be feasible for them to incorporate physical training
in daily life afterwards.
Boys in study 2 train reaching and lifting movements,
since reaching is one of the tasks with a high priority in
potential users of an arm support[45]. Boys train their
non-dominant arm as this arm is used less than the
dominant arm in functional acitivities[46]. Therefore,
training effects are expected to be larger for the non-
dominant arm. Nevertheless, it may be difficult for boys
to perform activities (like eating and scratching) with
their non-dominant arm.
Study outcomes
In this study, reliable functional scales are used, such as
the MFM, as well as timed tests that have clinically
meaningful endpoints[47] and that are sufficiently sensi-
tive to detect therapy related gains[48]. Indeed, outcome
measures should be reliable and sensitive to allow for an
adequate power in trials with a relatively small sample
size. As no suitable ergometry test or arm motor function
test is available for (non-ambulant) boys with NMD, a
Six-Minute Bicycle test and the ARAT have been selected
as primary outcomes. Pilot studies showed that the
applied Six-Minute Bicycle test was feasible for both
ambulant and recently wheelchair-dependent boys with
DMD. The ARAT proved to be useful in a wheelchair-
dependent boy with DMD as well (unpublished data). In
addition, we used an upper extremity protocol to quanti-
tatively measure arm motor function[49] with an eight
camera motion analysis system( V i c o nM o t i o nS y s t e m s ,
Ltd, Oxford, UK). It has been shown that such a system
can accurately measure task performance with an upper-
limb orthosis[45]. Arm motor function has never been
measured quantitatively before in boys with DMD, which
may be of value because of its continuous properties and
presumably greater sensitivity to change[50].
Strategies to increase therapy compliance
From a previous study, it can be concluded that home-
based cycling programs for children are feasible and
show good adherence rates[51]. A home-based program
allows boys to train at times that are convenient for them
and reduces travel time. However, a home-based pro-
gram requires great discipline from boys and their
families, and several aspects need attention to optimize
therapy compliance. One of these aspects, according to
the Social Cognitive Theory[52], is that the social envir-
onment (e.g. family and school) is essential for a change
in health behavior. Therefore, to optimize therapy com-
pliance, parents are asked to stimulate their boys by
reminding them to perform their exercises. In addition,
siblings can be role models by being physically active
themselves. Other strategies that are used to enhance
behavioral change and optimize therapy compliance are
specific goal setting[53] and reduction of perceived bar-
riers[54]. For this reason, as described previously, all boys
sign a training contract including an agreement on the
training moments. The barriers that boys or their parents
might perceive are discussed beforehand. In addition, the
boys in study 1 are recommended to train while watching
the television to make the training more pleasurable.
Expected products
The NUD study is the first clinical trial that examines
the effects of low-intensity physical training on muscle
endurance and functional abilities in boys with DMD. It
will be a start to fill the current gap in our knowledge
about the efficacy of physical training in these boys and
will increase our insight into what type of physical train-
ing should be recommended. Although the NUD study
f o c u s e so nc h i l d r e nw i t hD M D ,t h er e s u l t sm a yb e
(partly) applicable to other neuromuscular disorders in
childhood. Results of the NUD study are expected by
the end of 2010.
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